Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

23.01
-0.3900-1.67%
Post-market: 23.080.0700+0.30%18:43 EST
Volume:309.47K
Turnover:7.32M
Market Cap:1.56B
PE:-20.31
High:24.87
Open:23.55
Low:22.98
Close:23.40
52wk High:26.30
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:0.26
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1329
EPS(LYR):-0.9176
ROE:-86.99%
ROA:-48.90%
PB:16.82
PE(LYR):-25.08

Loading ...

Earning Preview: Pulse Biosciences this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
Feb 12

Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Reports Disposal of Common Shares

Reuters
·
Feb 12

Pulse Biosciences (PLSE) Receives a Buy from Mizuho Securities

TIPRANKS
·
Feb 10

What's Going With Pulse Biosciences Stock On Monday?

Benzinga_recent_news
·
Feb 09

A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge

Simply Wall St.
·
Feb 09

Pulse Biosciences Inc. Files Initial Beneficial Ownership Statement for Director Maria Sainz

Reuters
·
Feb 07

Top Midday Gainers

MT Newswires Live
·
Feb 07

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live
·
Feb 07

Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Study Results

TIPRANKS
·
Feb 06

Pulse Biosciences präsentiert erfolgreiche Studiendaten zum nPulse Cardiac Catheter System bei Vorhofflimmern

Reuters
·
Feb 06

Pulse Biosciences Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht

Reuters
·
Feb 05

Pulse Biosciences Reports Positive 12-Month Data for Nanosecond PFA Catheter in Atrial Fibrillation Study

Reuters
·
Feb 03

Mizuho Securities Initiates Coverage on Pulse Biosciences With Outperform Rating

MT Newswires Live
·
Jan 30

Pulse Biosciences Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $25

THOMSON REUTERS
·
Jan 30

Pulse Biosciences initiated with an Outperform at Mizuho

TIPRANKS
·
Jan 30

New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences (PLSE)

Simply Wall St.
·
Jan 13

Assessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation

Simply Wall St.
·
Jan 09

Pulse Biosciences Appoints Maria Sainz to Board of Directors

Reuters
·
Jan 09

Pulse Biosciences Unveils Late-Breaking Data from nPulse Cardiac Catheter Study at AF Symposium

Reuters
·
Jan 06

Pulse Biosciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 30, 2025